ImaginAb and Cyclotek Enter into Manufacturing and Distribution Agreement for CD8 ImmunoPET Agent in Australia

/in

Inglewood, California, October 17th 2022 – ImaginAb, Inc., a global biotechnology company focused on developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPET) imaging agent and radiopharmaceutical therapies (RPT) products, is pleased to announce the completion of a Master Services Agreement with Cyclotek, a leading radiopharmaceutical manufacturer in Australia and New Zealand, for the commercial manufacturing and distribution of […]

Read more

Verona Pharma Announces Analyses Demonstrating Ensifentrine Reduced Exacerbation Rates Across Subgroups in Phase 3 ENHANCE-2 Trial for COPD

/in

LONDON and RALEIGH, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces additional exacerbation* subgroup analyses from the Phase 3 ENHANCE-2 (“Ensifentrine as a Novel inHAled Nebulized COPD thErapy”) trial in chronic obstructive pulmonary disease (“COPD”). Top-line results from the trial are available on Verona Pharma’s […]

Read more

Muna Therapeutics Awarded $4.9M Grant from The Michael J. Fox Foundation for Parkinson’s Research Supports Development of Disease Modifying Therapy for Parkinson’s Disease

/in

Copenhagen, Denmark and Boston, US, 11th October 2022 – Muna Therapeutics (Muna), a biopharmaceutical company discovering and developing novel therapeutics for the treatment of Parkinson’s disease and other neurodegenerative disorders, announced today that it has been awarded a $4.9 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).  Read more…

Read more

Novo Nordisk Foundation establishes fellowships with four top international universities

/in

The Novo Nordisk Foundation is expanding and extending its Interdisciplinary Postdoctoral Fellowship Programme, thereby enabling ambitious researchers in the natural and technical sciences and life sciences to boost their careers with a research stay at one of several top international universities. Read more…

Read more

Novo Nordisk Foundation and World Food Programme launch partnership to improve food systems in Rwanda and Uganda

/in

Copenhagen – The Novo Nordisk Foundation and the United Nations World Food Programme (WFP) have sealed a partnership to further advance WFP’s homegrown school feeding and smallholder farmer support programmes in Rwanda and Uganda. The Novo Nordisk Foundation has committed a US$4.1 million grant to improve health, nutrition, food security and incomes for marginalized and vulnerable […]

Read more
© Optimum Strategic Communications.